Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY AND SERIES A PREFERRED STOCK

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY AND SERIES A PREFERRED STOCK - USD ($)
$ in Thousands
Series A Preferred stock
Preferred Stock
Stockholders' (deficit) equity
Common stock
Treasury stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Noncontrolling interests
Total
Balance at Dec. 31, 2024   $ 45,891 $ 3 $ (18,202) $ 67,118   $ (3,028) $ (2,645) $ 43,246
Balance (in shares) at Dec. 31, 2024     31,037,843            
Stockholders' Equity                  
Stock-based compensation   1,632     1,632       1,632
Stock-based compensation (in shares)     61,453            
Issuance of vested restricted shares, net of tax withholding   (129)     (129)       (129)
Issuance of vested restricted shares, net of tax withholding (in shares)     54,557            
Purchase of treasury stock   (307)   (307)         $ (307)
Purchase of treasury stock (in shares)     (110,595)           100,000
Series A Preferred Stock paid-in kind dividend and accretion   (7,591)     (6,616) $ (975)     $ (7,591)
Loss on foreign currency translation, net   (13)         (13)   (13)
Net income (loss)   975       975   (353) 622
Balance at Mar. 30, 2025   40,458 $ 3 (18,509) 62,005   (3,041) (2,998) 37,460
Balance (in shares) at Mar. 30, 2025     31,043,258            
Series A preferred stock, beginning balance at Dec. 31, 2024 $ 158,085                
Series A preferred stock, beginning balance (Shares) at Dec. 31, 2024 160,000                
Temporary Equity                  
Series A Preferred Stock paid-in kind dividend and accretion $ 7,591                
Series A preferred stock, ending balance at Mar. 30, 2025 $ 165,676                
Series A preferred stock, ending balance (Shares) at Mar. 30, 2025 160,000                
Balance at Dec. 28, 2025   (75,838) $ 3 (19,308) 39,712 (93,216) (3,029) (3,989) (79,827)
Balance (in shares) at Dec. 28, 2025     31,242,344            
Stockholders' Equity                  
Stock-based compensation   1,134     1,134       1,134
Stock-based compensation (in shares)     122,892            
Issuance of vested restricted shares, net of tax withholding   (209)     (209)       $ (209)
Issuance of vested restricted shares, net of tax withholding (in shares)     141,125            
Purchase of treasury stock (in shares)                 0
Series A Preferred Stock paid-in kind dividend and accretion   (9,395)     (9,395)       $ (9,395)
Loss on foreign currency translation, net   (26)         (26)   (26)
Net income (loss)   3,202       3,202   (213) 2,989
Balance at Mar. 29, 2026   $ (81,132) $ 3 $ (19,308) $ 31,242 $ (90,014) $ (3,055) $ (4,202) (85,334)
Balance (in shares) at Mar. 29, 2026     31,506,361            
Series A preferred stock, beginning balance at Dec. 28, 2025 $ 191,303               $ 191,303
Series A preferred stock, beginning balance (Shares) at Dec. 28, 2025 160,000               160,000
Temporary Equity                  
Series A Preferred Stock paid-in kind dividend and accretion $ 9,395                
Series A preferred stock, ending balance at Mar. 29, 2026 $ 200,698               $ 200,698
Series A preferred stock, ending balance (Shares) at Mar. 29, 2026 160,000               160,000